Is MEDIF or PLD a better dividend investment in 2026?

MEDIF currently yields 4345.46% with a 5% 5-year dividend growth rate. PLD yields 3.10% with 5% growth. The better choice depends on your goal: MEDIF offers higher current income.

What is the dividend yield difference between MEDIF and PLD?

MEDIF has a forward dividend yield of 4345.46% ($2.00/share annually). PLD yields 3.10% ($4.10/share annually). The yield gap is 4342.36 percentage points.

Home › Compare › MEDIF vs PLD

MEDIF vs PLD: Dividend Comparison 2026

MEDIF yields 4345.46% · PLD yields 3.10%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 MEDIF wins by $15969693446282.88M in total portfolio value

INVESTMENT

TIME HORIZON10 years

MEDIF

● Live price

4345.46%

Share price

$0.05

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$15969693446288.79M

Annual income

$15,278,069,441,942,714,000.00

Full MEDIF calculator →

PLD

● Live price

3.10%

Share price

$132.18

Annual div

$4.10

5Y div CAGR

74.4%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$5.91M

Annual income

$4,750,725.19

Full PLD calculator →

Portfolio growth — MEDIF vs PLD

📍 MEDIF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	MEDIF	PLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, MEDIF + PLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

MEDIF pays

PLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MEDIF

Annual income on $10K today (after 15% tax)

$369,364.48/yr

After 10yr DRIP, annual income (after tax)

$12,986,359,025,651,306,000.00/yr

PLD

Annual income on $10K today (after 15% tax)

$263.66/yr

After 10yr DRIP, annual income (after tax)

$4,038,116.41/yr

At 15% tax rate, MEDIF beats the other by $12,986,359,025,647,268,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MEDIF + PLD for your $10,000?

MEDIF: 50%PLD: 50%

100% PLD50/50100% MEDIF

Portfolio after 10yr

$7984846723147.35M

Annual income

$7,639,034,720,973,733,000.00/yr

Blended yield

95.67%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

MEDIF

No analyst data

Altman Z

-2.9

Piotroski

2/9

PLD

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$136.00

+2.9% upside vs current

Range: $119.00 — $155.00

Altman Z

1.9

Piotroski

5/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MEDIF buys

PLD buys

No recent congressional trades found for MEDIF or PLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricMEDIFPLD

Forward yield	4345.46% ✓	3.10%
Annual dividend / share	$2.00	$4.10 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	74.4% ✓
Portfolio after 10y	$15969693446288.79M ✓	$5.91M
Annual income after 10y	$15,278,069,441,942,714,000.00 ✓	$4,750,725.19
Total dividends collected	$15922667488789.34M ✓	$5.78M
Payment frequency	quarterly	quarterly
Sector	Stock	REIT

Year-by-year: MEDIF vs PLD ($10,000, DRIP)

Year	MEDIF Portfolio	MEDIF Income/yr	PLD Portfolio	PLD Income/yr	Gap
1← crossover	$445,246	$434,546.44	$11,241	$540.96	+$434.0K → MEDIF
2	$18,558,681	$18,082,267.04	$13,019	$991.13	+$18.55M → MEDIF
3	$724,251,944	$704,394,155.22	$15,801	$1,870.97	+$724.24M → MEDIF
4	$26,465,566,588	$25,690,617,008.13	$20,609	$3,701.21	+$26465.55M → MEDIF
5	$905,687,152,836	$877,368,996,586.58	$29,919	$7,867.97	+$905687.12M → MEDIF
6	$29,029,592,495,582	$28,060,507,242,048.22	$50,631	$18,617.74	+$29029592.44M → MEDIF
7	$871,632,797,918,927	$840,571,133,948,653.80	$105,528	$51,352.20	+$871632797.81M → MEDIF
8	$24,520,223,407,609,444	$23,587,576,313,836,190.00	$287,364	$174,449.42	+$24520223407.32M → MEDIF
9	$646,377,574,155,211,500	$620,140,935,109,069,400.00	$1,081,760	$774,280.77	+$646377574154.13M → MEDIF
10	$15,969,693,446,288,792,000	$15,278,069,441,942,714,000.00	$5,908,209	$4,750,725.19	+$15969693446282.88M → MEDIF

MEDIF vs PLD: Complete Analysis 2026

MEDIF — Stock

MediPharm Labs Corp., a pharmaceutical company, produces and sells pharmaceutical-quality cannabis oil and concentrates, and advanced derivative products in Canada, Australia, Germany, and internationally. It formulates, processes, packages, and distributes cannabis extracts and advanced cannabinoid-based products. The company also provides GMP flower sourcing, packaging, and distribution services. MediPharm Labs Corp. was founded in 2015 and is headquartered in Barrie, Canada.

Full MEDIF Calculator →

PLD — REIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →

📬

Get this MEDIF vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MEDIF vs SCHD MEDIF vs JEPI MEDIF vs O MEDIF vs KO MEDIF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.